Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.

Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.
复制标题

DOI:
10.1002/lt.24334
复制
发表时间:
2015-12
期刊:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
影响因子:
--
通讯作者:
Lai JC
Lai JC
中科院分区:
其他
文献类型:
--
作者:
Wang CW;Covinsky KE;Feng S;Hayssen H;Segev DL;Lai JC

文献摘要

被引文献

相似文献

老年人肝移植的流行导致考虑肝移植(LT)的≥65奥尔兹数量急剧增加。然而,临床医生缺乏客观的措施来对老年患者进行风险分层。我们的目的是确定是否短期身体功能电池(SPPB),一个良好的验证老年人的身体功能的措施,有更大的预后价值,在老年人与年轻的LT候选人。实验室MELD ≥12的LT列出的成人门诊患者使用SPPB进行身体功能测试,包括步态速度、椅子站立和平衡。患者按年龄(“年轻”= <65岁;“老年”= ≥65岁)和SPPB(“受损”= ≤9;“稳健”= >9)分类。竞争风险模型将年龄和SPPB与等待名单死亡/除名相关联。在463例LT候选者中,21% ≥65岁; 18%死亡/除名。年龄较大的患者步态较慢(1.1 vs.1.3 m/sec; p<0.001),椅子站立有较慢的趋势(12.8 vs.11.8 sec; p=0.06),能够完成所有平衡测试的比例较小(65 vs.78%; p=0.01);年龄较大的患者SPPB低于年轻患者(10 vs.11; p=0.01)。与作为参考组的年轻健壮患者相比,年轻受损患者(HR 1.77; p=0.03)和老年受损患者(HR 2.70; p=0.003)的等待名单死亡风险显著更高,但老年健壮患者的风险无差异(HR 1.38; p=0.35)[等同性检验p=0.01]。调整MELD-Na后,与年轻健康患者相比,仅老年受损患者的等待名单死亡风险增加(HR 2.36; p=0.01)[等同性检验p=0.05]。总之,SPPB评估的功能损害可预测≥ 65岁LT候选者的死亡/除名,与MELD-Na无关。进一步研究基于活动的干预措施,以减少这一人群的不良移植结果是必要的。
The emerging epidemic of older cirrhotics has led to a sharp increase in the number of ≥65 year olds considering liver transplantation (LT). However, clinicians lack objective measures to risk stratify older patients. We aimed to determine whether the Short Physical Performance Battery (SPPB), a well-validated geriatric measure of physical function, has greater prognostic value in older versus younger LT candidates. Adult outpatients listed for LT with laboratory MELD ≥12 underwent physical function testing using the SPPB, consisting of gait speed, chair stands, and balance. Patients were categorized by age (“younger”= <65 years; “older”= ≥65 years) and SPPB (“impaired”= ≤9; “robust”= >9). Competing risks models associated age and SPPB with wait-list death/delisting. Of 463 LT candidates, 21% were ≥65 years; 18% died/delisted. Older patients had slower gait (1.1 vs.1.3m/sec; p<0.001), a trend of slower chair stands (12.8 vs.11.8sec; p=0.06), and a smaller proportion able to complete all balance tests (65 vs.78%; p=0.01); SPPB was lower in older vs. younger patients (10 vs.11; p=0.01). When compared to younger robust patients as a reference group, younger impaired patients (HR 1.77; p=0.03) and older impaired patients (HR 2.70; p=0.003) had significantly higher risk of wait-list mortality, but there was no difference in risk for older robust patients (HR 1.38; p=0.35) [test of equality p=0.01]. After adjustment for MELD-Na, only older impaired patients had an increased risk of wait-list mortality compared to younger robust patients (HR 2.36; p=0.01) [test of equality p=0.05]. In conclusion, functional impairment, as assessed by the SPPB, predicts death/delisting for LT candidates ≥ 65 years independent of MELD-Na. Further research into activity-based interventions to reduce adverse transplant outcomes in this population is warranted.